SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041002
Filing Date
2019-11-06
Accepted
2019-11-06 16:06:40
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20190930.htm 10-Q 2072227
2 EX-10.1 elox-ex101_267.htm EX-10.1 140778
3 EX-31.1 elox-ex311_9.htm EX-31.1 8714
4 EX-31.2 elox-ex312_7.htm EX-31.2 9171
5 EX-32.1 elox-ex321_8.htm EX-32.1 6898
6 EX-32.2 elox-ex322_6.htm EX-32.2 6788
  Complete submission text file 0001564590-19-041002.txt   9001990

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT elox-20190930.xml EX-101.INS 2425996
8 XBRL TAXONOMY EXTENSION SCHEMA elox-20190930.xsd EX-101.SCH 53136
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20190930_cal.xml EX-101.CAL 66398
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20190930_def.xml EX-101.DEF 149809
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20190930_lab.xml EX-101.LAB 400385
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20190930_pre.xml EX-101.PRE 297601
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 191196295
SIC: 8731 Services-Commercial Physical & Biological Research